These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11523383)

  • 1. Methods for exploring heterogeneity in meta-analysis.
    Song F; Sheldon TA; Sutton AJ; Abrams KR; Jones DR
    Eval Health Prof; 2001 Jun; 24(2):126-51. PubMed ID: 11523383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis: when and how.
    Imperiale TF
    Hepatology; 1999 Jun; 29(6 Suppl):26S-31S. PubMed ID: 10386080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring sources of heterogeneity in systematic reviews of diagnostic tests.
    Lijmer JG; Bossuyt PM; Heisterkamp SH
    Stat Med; 2002 Jun; 21(11):1525-37. PubMed ID: 12111918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in ecological and evolutionary meta-analyses: its magnitude and implications.
    Senior AM; Grueber CE; Kamiya T; Lagisz M; O'Dwyer K; Santos ES; Nakagawa S
    Ecology; 2016 Dec; 97(12):3293-3299. PubMed ID: 27912008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpretation of tests of heterogeneity and bias in meta-analysis.
    Ioannidis JP
    J Eval Clin Pract; 2008 Oct; 14(5):951-7. PubMed ID: 19018930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Practice of systematic reviews. VII. Pooling of results from observational studies].
    Zeegers MP; Heisterkamp SH; Kostense PJ; van der Windt DA; Scholten RJ
    Ned Tijdschr Geneeskd; 2000 Jul; 144(29):1393-7. PubMed ID: 10923147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The practice of systematic reviews. V. Heterogeneity between studies and subgroup analysis].
    Scholten RJ; Assendelft WJ; Kostense PJ; Bouter LM
    Ned Tijdschr Geneeskd; 1999 Apr; 143(16):843-8. PubMed ID: 10347653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta-analysis of time-to-event outcomes.
    Smith CT; Williamson PR; Marson AG
    J Eval Clin Pract; 2005 Oct; 11(5):468-78. PubMed ID: 16164588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials.
    Baujat B; Mahé C; Pignon JP; Hill C
    Stat Med; 2002 Sep; 21(18):2641-52. PubMed ID: 12228882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HELOW: a program for testing extreme homogeneity in meta-analysis.
    Zintzaras E; Ioannidis JP
    Comput Methods Programs Biomed; 2014 Nov; 117(2):383-6. PubMed ID: 25023534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes.
    Smith CT; Williamson PR; Marson AG
    Stat Med; 2005 May; 24(9):1307-19. PubMed ID: 15685717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistics for quantifying heterogeneity in univariate and bivariate meta-analyses of binary data: the case of meta-analyses of diagnostic accuracy.
    Zhou Y; Dendukuri N
    Stat Med; 2014 Jul; 33(16):2701-17. PubMed ID: 24903142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversies in meta-analysis: the case of the trials of serum cholesterol reduction.
    Thompson SG
    Stat Methods Med Res; 1993; 2(2):173-92. PubMed ID: 8261257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple technique investigating baseline heterogeneity helped to eliminate potential bias in meta-analyses.
    Hicks A; Fairhurst C; Torgerson DJ
    J Clin Epidemiol; 2018 Mar; 95():55-62. PubMed ID: 29032245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extreme between-study homogeneity in meta-analyses could offer useful insights.
    Ioannidis JP; Trikalinos TA; Zintzaras E
    J Clin Epidemiol; 2006 Oct; 59(10):1023-32. PubMed ID: 16980141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of methods for fixed effects meta-analysis of individual patient data with time to event outcomes.
    Tudur Smith C; Williamson PR
    Clin Trials; 2007; 4(6):621-30. PubMed ID: 18042571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring heterogeneity in meta-analyses: needs, resources and challenges.
    Xu H; Platt RW; Luo ZC; Wei S; Fraser WD
    Paediatr Perinat Epidemiol; 2008 Jan; 22 Suppl 1():18-28. PubMed ID: 18237348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual patient-level and study-level meta-analysis for investigating modifiers of treatment effect.
    Teramukai S; Matsuyama Y; Mizuno S; Sakamoto J
    Jpn J Clin Oncol; 2004 Dec; 34(12):717-21. PubMed ID: 15640501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing heterogeneity in meta-analysis: Q statistic or I2 index?
    Huedo-Medina TB; Sánchez-Meca J; Marín-Martínez F; Botella J
    Psychol Methods; 2006 Jun; 11(2):193-206. PubMed ID: 16784338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.